(Q30975449)

27 June 2017

1 reference

title

The utility of superparamagnetic contrast agents in MRI: theoretical consideration and applications in the cardiovascular system (English)

1 reference

magnetic resonance imaging

27 June 2017

1 reference

1 reference

0 references

2

Lars Johansson

1 reference

27 June 2017

Atle Bjørnerud

1

1 reference

27 June 2017

language of work or name

1 reference

1 November 2004

1 reference

27 June 2017

1 reference

27 June 2017

volume

17

1 reference

27 June 2017

issue

7

1 reference

27 June 2017

page(s)

465-477

1 reference

Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging

27 June 2017

cites work

1 reference

NC100150 Injection, a preparation of optimized iron oxide nanoparticles for positive-contrast MR angiography

21 January 2018

1 reference

Gaussian approximation in the theory of MR signal formation in the presence of structure-specific magnetic field inhomogeneities. Effects of impermeable susceptibility inclusions.

21 January 2018

1 reference

Assessment of T1 and T2* effects in vivo and ex vivo using iron oxide nanoparticles in steady state--dependence on blood volume and water exchange

21 January 2018

1 reference

On the theoretical basis of perfusion measurements by dynamic susceptibility contrast MRI.

21 January 2018

1 reference

Effects of water exchange on the measurement of myocardial perfusion using paramagnetic contrast agents

21 January 2018

1 reference

Assessment of myocardial blood volume and water exchange: Theoretical considerations and in vivo results

21 January 2018

1 reference

Quantification of the effect of water exchange in dynamic contrast MRI perfusion measurements in the brain and heart

21 January 2018

1 reference

Direct comparison of an intravascular and an extracellular contrast agent for quantification of myocardial perfusion. Cardiac MRI Group

21 January 2018

1 reference

Determination of regional blood volume and intra-extracapillary water exchange in human myocardium using Feruglose: First clinical results in patients with coronary artery disease

21 January 2018

1 reference

Value of blood pool contrast agents in magnetic resonance angiography of the pelvis and lower extremities

21 January 2018

1 reference

Multicenter phase-II trial of safety and efficacy of NC100150 for steady-state contrast-enhanced peripheral magnetic resonance angiography

21 January 2018

1 reference

Three-dimensional contrast-enhanced MRI using an intravascular contrast agent for detection of traumatic intra-abdominal hemorrhage and abdominal parenchymal injuries: an experimental study.

21 January 2018

1 reference

[Superparamagnetic iron oxide enhanced MR angiography of the portal vein system]

21 January 2018

1 reference

A targeted contrast agent for magnetic resonance imaging of thrombus: implications of spatial resolution

21 January 2018

1 reference

Segmentation with gray-scale connectedness can separate arteries and veins in MRA.

21 January 2018

1 reference

Level-set-based artery-vein separation in blood pool agent CE-MR angiograms

21 January 2018

1 reference

Artery-vein separation via MRA--an image processing approach.

21 January 2018

1 reference

Highly automated segmentation of arterial and venous trees from three-dimensional magnetic resonance angiography (MRA).

21 January 2018

1 reference

Three-dimensional MR imaging of pulmonary vessels and parenchyma with NC100150 injection (Clariscan).

21 January 2018

1 reference

Improved cine cardiovascular magnetic resonance using Clariscan (NC100150 injection).

21 January 2018

1 reference

Benefit of T1 reduction for magnetic resonance coronary angiography: a numerical simulation and phantom study.

21 January 2018

1 reference

Initial experience with the intravascular contrast agent NC100150-injection (Clariscan) for breath-hold and navigator-gated magnetic resonance coronary artery imaging

21 January 2018

1 reference

Three-dimensional magnetic resonance coronary angiography using a new blood pool contrast agent: initial experience.

21 January 2018

1 reference

Improvement of image quality of non-invasive coronary artery imaging with magnetic resonance by the use of the intravascular contrast agent Clariscan (NC100150 injection) in patients with coronary artery disease.

21 January 2018

1 reference

Multislice breath-hold spiral magnetic resonance coronary angiography in patients with coronary artery disease: effect of intravascular contrast medium.

21 January 2018

1 reference

Use of the mean transit time of an intravascular contrast agent as an exchange-insensitive index of myocardial perfusion

21 January 2018

1 reference

Quantification of renal perfusion abnormalities using an intravascular contrast agent (part 2): results in animals and humans with renal artery stenosis

21 January 2018

1 reference

Improving spatiotemporal resolution of USPIO-enhanced dynamic imaging of rat kidneys.

21 January 2018

1 reference

USPIO-enhanced MR imaging of glycerol-induced acute renal failure in the rabbit.

21 January 2018

1 reference

Blood pool contrast-enhanced MRI detects suppression of microvascular permeability in early postinfarction reperfusion after nicorandil therapy.

21 January 2018

1 reference

Magnetic resonance imaging with superparamagnetic iron oxide particles for the detection of myocardial reperfusion

21 January 2018

1 reference

Neighborhood politics: the immunoregulatory function of organ-resident liver endothelial cells.

21 January 2018

1 reference

Macrophage labeling by SPIO as an early marker of allograft chronic rejection in a rat model of kidney transplantation

21 January 2018

1 reference

Magnetic resonance imaging detection of rat renal transplant rejection by monitoring macrophage infiltration.

21 January 2018

1 reference

Detection of inflammation following renal ischemia by magnetic resonance imaging

21 January 2018

1 reference

Reversibility of experimental acute renal failure in rats: assessment with USPIO-enhanced MR imaging

21 January 2018

1 reference

Superparamagnetic iron oxide-based method for quantifying recruitment of monocytes to mouse atherosclerotic lesions in vivo: enhancement by tissue necrosis factor-alpha, interleukin-1beta, and interferon-gamma

21 January 2018

1 reference

Iron-oxide-enhanced magnetic resonance imaging of atherosclerotic plaques: postmortem analysis of accuracy, inter-observer agreement, and pitfalls.

21 January 2018

1 reference

Magnetic resonance imaging of atherosclerotic plaques using superparamagnetic iron oxide particles.

21 January 2018

1 reference

A novel approach with magnetic resonance imaging used for the detection of lung allograft rejection

21 January 2018

1 reference

Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging

21 January 2018

1 reference

New Intravascular Contrast Agent Applied to Dynamic Contrast Enhanced Mr imaging of Human Breast Cancer

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/NBM.904

1 reference

27 June 2017

1 reference